This Article  • Full text  • PDF  • CME Course for This Article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (13)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Quality of Life  • Congestive Heart Failure/ Cardiomyopathy  • Psychiatry  • Depression  • Alert me on articles by topic

Healing the Broken-Hearted

Mary A. Whooley, MD

JAMA. 2006;295:2874-2881.

Major depressive disorder is a risk factor for the development of incident coronary heart disease events in healthy patients and for adverse cardiovascular outcomes in patients with established heart disease. Depression is present in 1 of 5 outpatients with coronary heart disease and in 1 of 3 outpatients with congestive heart failure, yet the majority of cases are not recognized or appropriately treated. It is not known whether treating depression improves cardiovascular outcomes, but antidepressant treatment with selective serotonin reuptake inhibitors is generally safe, alleviates depression, and improves quality of life. This article evaluates the importance of major depression in patients with cardiovascular disease, and provides practical guidance for identifying and treating this disorder.

Author Affiliation: Veterans Affairs Medical Center and University of California, San Francisco Medical Center.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Prospective Examination of Antidepressant Use and Its Correlates in Patients With Acute Coronary Syndrome
Grace et al.
Psychosomatics 2008;49:199-207.
ABSTRACT | FULL TEXT  

Effect of Selective Serotonin Reuptake Inhibitors on Cardiovascular Morbidity and Mortality
Von Ruden et al.
J CARDIOVASC PHARMACOL THER 2008;13:32-40.
ABSTRACT  

Pre-existent depression in the 2 weeks before an acute coronary syndrome can be associated with delayed presentation of the heart attack
Wong et al.
QJM 2008;101:137-144.
ABSTRACT | FULL TEXT  

Self-reported Medication Adherence and Cardiovascular Events in Patients With Stable Coronary Heart Disease: The Heart and Soul Study
Gehi et al.
Arch Intern Med 2007;167:1798-1803.
ABSTRACT | FULL TEXT  

Association of a Serotonin Transporter Polymorphism (5-HTTLPR) With Depression, Perceived Stress, and Norepinephrine in Patients With Coronary Disease: The Heart and Soul Study
Otte et al.
Am. J. Psychiatry 2007;164:1379-1384.
ABSTRACT | FULL TEXT  

Mend the Mind, but Mind the Bones!: Balancing Benefits and Potential Skeletal Risks of Serotonin Reuptake Inhibitors
Saag
Arch Intern Med 2007;167:1231-1232.
FULL TEXT  

Depression Is a Risk Factor for Mortality After Myocardial Infarction: Fact or Artifact?
Dickens et al.
J Am Coll Cardiol 2007;49:1834-1840.
ABSTRACT | FULL TEXT  

Psoriasis and Risk of Myocardial Infarction
Alevizos et al.
JAMA 2007;297:361-361.
FULL TEXT  

Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery Disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial
Lesperance et al.
JAMA 2007;297:367-379.
ABSTRACT | FULL TEXT